Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.
出版信息
Respiration. 1989;55 Suppl 2:1-44. doi: 10.1159/000195761.
PMID:2572034
Abstract
摘要
相似文献
1
Broxaterol: a new beta2-adrenoceptor agonist for the treatment of reversible airways disease. Proceedings of the satellite symposium. Budapest, September 8, 1988.溴沙特罗：一种用于治疗可逆性气道疾病的新型β2肾上腺素能受体激动剂。卫星研讨会会议记录。布达佩斯，1988年9月8日。
Respiration. 1989;55 Suppl 2:1-44. doi: 10.1159/000195761.
2
Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
Respiration. 1988;53(4):220-4. doi: 10.1159/000195423.
3
Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
Respiration. 1985;47(4):299-302. doi: 10.1159/000194786.
4
[Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
Pediatr Med Chir. 1989 Jan-Feb;11(1):61-3.
5
Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Respiration. 1989;55 Suppl 2:15-9. doi: 10.1159/000195765.
6
Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.对一种以压力定量气雾剂形式给药的新型支气管扩张化合物（溴沙特罗）的评估。
Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):101-4.
7
Role of broxaterol in bronchial hyperresponsiveness.
Respiration. 1989;55 Suppl 2:20-7. doi: 10.1159/000195766.
8
[Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
Arch Monaldi Mal Torace. 1987 Jul-Aug;42(4):383-8.
9
Broxaterol: therapeutic trials and safety profile.丙卡特罗：治疗试验与安全性概况。
Respiration. 1989;55 Suppl 2:28-40. doi: 10.1159/000195767.
10
A comparison of the bronchodilator effects of broxaterol and salbutamol.溴沙特罗与沙丁胺醇支气管扩张作用的比较。
Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):93-7.
Zotero 插件